文献速递关节外科

清创保留假体联合慢性抗生素抑制治疗急性感染的无菌翻修全关节置换术

Irrigation and Debridement With Chronic Antibiotic Suppression for the Management of Acutely Infected Aseptic Revision Total Joint Arthroplasties.
PubMed 文献 · J Arthroplasty · 2023-06-07

本研究基于关节登记系统纳入2000至2017年45例因急性假体周围感染接受清创保留假体(IDCR)的无菌翻修全关节置换术(33髋、12膝),89%接受抑制性抗生素治疗(SAT),平均随访7年。5年无感染再翻修生存率为80%,无感染再手术生存率为70%。作者认为,在特定患者中,IDCR联合SAT是翻修全关节置换术后急性感染的可行选择。

要点

  • 无菌翻修全关节置换术后急性感染行IDCR联合SAT,5年无感染再翻修生存率80%。
  • 5年无感染再手术生存率70%,无任何翻修生存率72%,无任何再手术生存率65%。
  • 13例因感染再手术中46%与初始感染为同一菌种。

核心结论

  • IDCR后5年,80%的假体无感染再翻修。
  • 作者认为,由于翻修全关节置换术中假体取出的代价通常较高,对特定患者而言,IDCR联合SAT是翻修全关节置换术后急性感染的可行选择。

研究设计与样本

  • 通过本院全关节登记系统识别2000至2017年因急性假体周围感染接受IDCR的无菌翻修全关节置换术45例(33髋、12膝)。
  • 急性血源性假体周围感染占56%,64%的假体周围感染涉及葡萄球菌属。
  • 所有患者接受4至6周静脉抗生素治疗,计划给予SAT(89%接受了SAT)。
  • 平均年龄71岁(范围41至90),女性占49%,平均体重指数30(范围16至60),平均随访7年(范围2至15)。
  • 证据等级为IV级。

主要发现

  • 5年无感染再翻修生存率为80%,无感染再手术生存率为70%。
  • 13例因感染再手术中,46%涉及与初始假体周围感染相同的菌种。
  • 5年无任何翻修生存率为72%,无任何再手术生存率为65%。
  • 5年无死亡生存率为65%。

临床怎么用

  • 作者认为,对特定患者,IDCR联合SAT是翻修全关节置换术后急性感染的可行选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Most data on irrigation and debridement with component retention (IDCR) as a treatment for acute periprosthetic joint infections (PJIs) focuses on primary total joint arthroplasties (TJAs). However, the incidence of PJI is greater after revisions. We investigated the outcomes of IDCR with suppressive antibiotic therapy (SAT) following aseptic revision TJAs. METHODS: Through our total joint registry, we identified 45 aseptic revision TJAs (33 hips, 12 knees) performed from 2000 to 2017 that were treated with IDCR for acute PJI. Acute hematogenous PJI was present in 56%. Sixty-four percent of PJIs involved Staphylococcus. All patients were treated with 4 to 6 weeks of intravenous antibiotics with the intention to treat with SAT (89% received SAT). The mean age was 71 years (range, 41 to 90), with 49% being women and a mean body mass index of 30 (range, 16 to 60). The mean follow-up was 7 years (range, 2 to 15). RESULTS: The 5-year survivorships free from re-revision for infection and reoperation for infection were 80% and 70%, respectively. Of the 13 reoperations for infection, 46% involved the same species as the initial PJI. The 5-year survivorships free from any revision and any reoperation were 72% and 65%, respectively. The 5-year survivorship free from death was 65%. CONCLUSION: At 5 years following IDCR, 80% of implants were free from re-revision for infection. As the penalty for implant removal is often high in revision TJAs, IDCR with SAT is a viable option for acute infection after revision TJAs in select patients. LEVEL OF EVIDENCE: IV.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Salmons HI, Bettencourt JW, Wyles CC, et al. Irrigation and Debridement With Chronic Antibiotic Suppression for the Management of Acutely Infected Aseptic Revision Total Joint Arthroplasties. J Arthroplasty. 2023. PMID: 37295625. doi:10.1016/j.arth.2023.05.092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。